Company
AT WEP CLINICAL, WE ARE WITH EVERY PATIENT
We are a Pharmaceutical Services Provider that specializes in Drug Development Programs, Treatment Access Solutions and Market Access and Commercialization
About Us
Leadership Team
Global Coverage
Partnerships
Testimonials
Careers
CRO Services
WEP CRO Built for Biotech
We are experienced in Phase 1 – IV trial delivery with proven track record of excellence supporting 60+ clinical programmes worldwide.

Research Objectives
Study Protocol
Funding & Resources
Regulatory & Ethics Approval
Country Selection
Feasibility & Site Selection
Planning and Preparation
Site Set-Up & Contracting
Vendor Selection
IRT
Drug Supply Management
Data Management Planning
Safety Management Planning
Medical Monitoring Planning
Site Training
Pre-Trial Site Visit
Study Startup
Patient Identification
Screening & Enrollollment
Site Support & Management
Patient Retention Strategies
Patient Concierge Service
Nursing Services
Patient Recruitment & Retention
Project Management
Site Monitoring
Drug Safety & Pharmacovigilance
Medical Monitoring
Quality Control and Assurance
Medical Affairs
Medical Writing
Regulatory Affairs
Mobile Nursing Solutions
Clinical Support services
Data Cleaning & Validation
Statistical Analysis
Data Compliance & Submission
Data Management
Data Management & Analysis
Close-Out Site Visits and Audits
Final Report Submission
Clinical Trial Publications
Post-Marketing Surveillance
Study Close Out & Reporting
Access Services
Access programs With Every Patient
Industry leader with over 16 years of experience designing and deliveing calue-driven Expanded Access (EAPs) and Post-Trial Access Programs.
Expanded Access Programs
Post-Trial Access
Post-Approval Named Patient
Market Access Solutions
WEP 3PL
Project Management
Real World Data
Pharmacovigilance
Advocacy
Therapeutic Expertise
WEP Insights
News & Media
CASE STUDIES

Expanded Access
Post-Approval Named Patient
Market Access
Nursing Solutions
All Case Studies
NEWS

01 Dec 2023
WEP CLINICAL HAS PARTNERED WITH PLUSULTRA PHARMA TO SUPPLY HYFTOR® TO PATIENTS IN EU/EEA COUNTRIES (WITH THE EXCEPTION OF GERMANY)

17 Jul 2023
WEP CLINICAL ANNOUNCES PARTNERSHIP WITH GERON CORPORATION FOR AN EXPANDED ACCESS PROTOCOL FOR IMETELSTAT

All News
RESOURCES

Sample Regulatory Assessment for Treatment Access Program
View resource
Sponsor Considerations for Post-Trial Access
View resource
All Resources

Company
AT WEP CLINICAL, WE ARE WITH EVERY PATIENT
We are a Pharmaceutical Services Provider that specializes in Drug Development Programs, Treatment Access Solutions and Market Access and Commercialization
About Us
Leadership Team
Global Coverage
Partnerships
Testimonials
Careers
CRO Services
WEP CRO Built for Biotech
We are experienced in Phase 1 – IV trial delivery with proven track record of excellence supporting 60+ clinical programmes worldwide.

Research Objectives
Study Protocol
Funding & Resources
Regulatory & Ethics Approval
Country Selection
Feasibility & Site Selection
Planning and Preparation
Site Set-Up & Contracting
Vendor Selection
IRT
Drug Supply Management
Data Management Planning
Safety Management Planning
Medical Monitoring Planning
Site Training
Pre-Trial Site Visit
Study Startup
Patient Identification
Screening & Enrollollment
Site Support & Management
Patient Retention Strategies
Patient Concierge Service
Nursing Services
Patient Recruitment & Retention
Project Management
Site Monitoring
Drug Safety & Pharmacovigilance
Medical Monitoring
Quality Control and Assurance
Medical Affairs
Medical Writing
Regulatory Affairs
Mobile Nursing Solutions
Clinical Support services
Data Cleaning & Validation
Statistical Analysis
Data Compliance & Submission
Data Management
Data Management & Analysis
Close-Out Site Visits and Audits
Final Report Submission
Clinical Trial Publications
Post-Marketing Surveillance
Study Close Out & Reporting
Access Services
Access programs With Every Patient
Industry leader with over 16 years of experience designing and deliveing calue-driven Expanded Access (EAPs) and Post-Trial Access Programs.
Expanded Access Programs
Post-Trial Access
Post-Approval Named Patient
Market Access Solutions
WEP 3PL
Project Management
Real World Data
Pharmacovigilance
Advocacy
Therapeutic Expertise
WEP Insights
News & Media
CASE STUDIES

Expanded Access
Post-Approval Named Patient
Market Access
Nursing Solutions
All Case Studies
NEWS

01 Dec 2023
WEP CLINICAL HAS PARTNERED WITH PLUSULTRA PHARMA TO SUPPLY HYFTOR® TO PATIENTS IN EU/EEA COUNTRIES (WITH THE EXCEPTION OF GERMANY)

17 Jul 2023
WEP CLINICAL ANNOUNCES PARTNERSHIP WITH GERON CORPORATION FOR AN EXPANDED ACCESS PROTOCOL FOR IMETELSTAT

All News
RESOURCES

Sample Regulatory Assessment for Treatment Access Program
View resource
Sponsor Considerations for Post-Trial Access
View resource
All Resources

ResourcesWep Clinical2024-09-19T13:32:19+01:00

Resources

All Resources|
Real World Data Resources|
Market Access Resources|
Expanded Access Resources|
Open Label Extensions Resources|
Post-Approval Patient Programs Resources|

Sample Regulatory Assessment for Treatment Access Program

4th December 2024/

Sponsor Considerations for Post-Trial Access

11th November 2024/

Harnessing Real-World Data for Market Access Success

24th July 2024/

Step-by-step EAP Management Process

16th July 2024/

Navigating Asset Transitions that include EAPs

9th May 2024/

Building Stakeholder Engagement Through EAPs

4th March 2024/

International Recognition Procedure

19th December 2023/

Voluntary Scheme for Branded Medicines, Pricing, Access and Growth (VPAG)

13th December 2023/

Managing Patient Requests For Investigational Medicines

8th December 2023/

EU Health Technology Assessments

2nd November 2023/

Value of Real World Data in EAP

21st July 2022/

PA-NPP Product Uptake By Country

25th November 2021/

EAP Versus OLE Study

20th January 2021/

Sponsor Considerations for EAPs

11th December 2020/

Expanded Access Policy Templates

5th March 2020/

NEED MORE INFORMATION?

Facebook Linkedin

Privacy & Cookie Policy
Terms & Conditions
Ethics and Compliance

Privacy & Cookie Policy
Terms & Conditions
Ethics and Compliance

Need more information?

Facebook Twitter Linkedin

Privacy & Cookie Policy
Terms & Conditions
Ethics and Compliance

Privacy & Cookie Policy
Terms & Conditions
Ethics and Compliance